TAG-18161-81592 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-13
Registered in v-safe
2021-01-13
Dose 1 — Moderna
2021-01-13
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-09
Dose 2 — Moderna
2021-02-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-11
Survey response — days 1–6 daily, dose 2
MedDRA: Unevaluable event — Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Speech

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-02-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-08-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-09
Dose 3 — Moderna
2021-11-12
Survey response — days 1–6 daily, dose 3
MedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Runny nose, cold symptoms

MedDRA releases: 2024-11 · check-in free text available
2021-11-13
Survey response — days 1–6 daily, dose 3
MedDRA: Nasopharyngitis — Feeling: Good · Site: Pain

Free text: Cold-like symptoms

MedDRA releases: 2024-11 · check-in free text available
2021-11-16
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-25
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-30
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-09
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-16
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-22
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-08
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-12
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-11
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-13	Moderna
2	2021-02-09	Moderna
3	2021-11-09	Moderna	No

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-11

Systemic reaction (other): Speech

Release 10 — days 1–6 daily, dose 3

2021-11-12

Systemic reaction (other): Runny nose, cold symptoms

2021-11-13

Systemic reaction (other): Cold-like symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Nasopharyngitis	·	·	✓
SRO	Rhinorrhoea	·	·	✓
SRO	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release